STK33 Antibody (YA2085)(PBS only)
(Synonyms: STK33; Serine/threonine-protein kinase 33)STK33 Antibody (YA2085) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to STK33.
-
Host:
Rabbit
-
Isotype:
IgG
-
Application:
WB, IHC-F, IHC-P, ICC/IF
-
Reactivity :
Human
-
Formulation:
Supplied in PBS, pH 7.4.
-
Conjugation:
Non-conjugated
Applications
| Application |
WB
WB: Western Blot
|
IHC-P
IHC-P: Immunohistochemistry-Paraffin
|
ICC/IF
ICC/IF: Immunocytochemistry/
Immunofluorescence |
|---|---|---|---|
| Dilution Ratio | 1:500-1:1000 | 1:100-1:200 | 1:500-1:1000 |
Product Details
STK33 Antibody (YA2085) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to STK33.
-
Host Rabbit
-
Species ReactivityHuman
-
Observed Molecular WeightObserved band size: 58 kDaNote: Due to possible protein modifications or aggregation, the molecular weight should be confirmed by actual measurement, and the predicted value is for reference only.
-
Calculated Molecular Weight Predicted band size: 58 kDa
Recombinant protein of human STK33
Affinity Purified
Non-conjugated
IgG
Product Properties
-
Appearance
Solution
-
Formulation
Supplied in PBS, pH 7.4.
-
Storage & Stability
Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.
-
Shipping
Shipping with blue ice.
Verification Images
-
Western blot analysis was performed on extracts from Jurkat (lane 1, 15 μg), 293 (lane 2, 15 μg), HT-1080 (lane 3, 15 μg), and A431 (lane 4, 15 μg) using STK33 Rabbit mAb. Proteins were transferred to a PVDF membrane and blocked with 5% non - fat milk in TBST at 4°C overnight. The primary antibody (1:1000 dilution) and the loading control antibody (beta-Actin(HRP), HY-P80993, 1:5000 dilution) was incubated in 5% non-fat milk in TBST for 1 hour at 37°C. Goat Anti - Rabbit IgG - HRP Secondary Antibody (1:20000 dilution) was then applied for 40 minutes at 37°C.
Background
-
Function
Serine/Threonine Kinase 33 (STK33) plays a pivotal role in cancer cell proliferation and metastasis by phosphorylating serine and threonine residues on proteins, thereby regulating crucial cellular processes such as signal transduction, DNA replication, cell differentiation, proliferation, apoptosis, and tumor development. STK33 is overexpressed in various cancers, including pancreatic, lung, and liver cancers, compared to non-cancerous tissues. Notably, STK33 activates the PI3K/Akt/mTOR signaling pathway in gastric cancer, promoting metastasis. Additionally, the STK33/ERK2 signaling pathway contributes to the tumorigenesis of colorectal cancer by phosphorylating ERK2, enhancing its activity and promoting cancer progression. STK33's involvement in cancer development underscores its importance in oncology research.[1][2].
-
Subcellular Localization
Cytoplasm; Cytoplasm, cytoskeleton; Cytoplasm, perinuclear region
-
Expression
Tissue_specificity:Highly expressed in testis, fetal lung and heart, followed by pituitary gland, kidney, interventricular septum, pancreas, heart, trachea, thyroid gland and uterus. Weak hybridization signals were observed in the following tissues: amygdala, aorta, esophagus, colon ascending, colon transverse, skeletal muscle, spleen, peripheral blood leukocyte, lymph node, bone marrow, placenta, prostate, liver, salivary gland, mammary gland, some tumor cell lines, fetal brain, fetal liver, fetal spleen and fetal thymus. No signal at all was detectable in RNA from tissues of the nervous system -
Isoforms & Post-Translational Modification
Q9BYT3 has 2 isomers: Q9BYT3-1: 57831 Da (predicted); Q9BYT3-2: 50176 Da (predicted).
Autophosphorylated -
Subunit
Homodimer
-
SwissProt ID
-
Synonyms
STK33; Serine/threonine-protein kinase 33
-
Research Field
Signal Transduction
Documentation
References
[1]. Jiang H, et al. Serine/Threonine Kinase (STK) 33 promotes the proliferation and metastasis of human esophageal squamous cell carcinoma via inflammation-related pathway. Pathol Res Pract. 2024 Feb;254:155154. [Content Brief]
[2]. Zhang S, et al. STK33/ERK2 signal pathway contribute the tumorigenesis of colorectal cancer HCT15 cells. Biosci Rep. 2019 Mar 1;39(3):BSR20182351. [Content Brief]